Public Policy

Legal Medical Cannabis Displacing Alcohol Use?

Follow Us!Share This!The impact of medical cannabis on prescription drug use is becoming well known. Research presented at the Eleventh National Clinical Conference on Cannabis Therapeutics showed that the legal availability of medical cannabis has led many people to reduce their use of opioids and other prescribed medications, and also that the number of prescriptions being written for opioids, anti-depressants, sleeping pills, and some other medications appears to have declined in states with medical marijuana laws. So what about the…
Read more

Alcohol, News, Public Policy

House Votes To Keep Medical Cannabis Protections In Place Until Dec 22

Follow Us!Share This!The US House of Representatives on Thursday, Dec. 7, 2017, voted to keep protections in place that prevent the Department of Justice from going after state-legal medical cannabis businesses. The bill they approved is not the annual appropriations bill, rather it is a continuing resolution that only keeps the federal government funded and operating through December 22. The Rohrabacher-Blumenauer Amendment is a “rider” that was added to the Commerce, Justice Science, and Related Agencies appropriations legislation. That bill…
Read more

Cannabis Industry, News, Public Policy, State Laws

Medical Cannabis as a Substitute for Prescription Drugs

Follow Us!Share This!Evidence continues to mount that medical cannabis is a viable substitute for several types of prescription medication, including opioid painkillers, anti-anxiety drugs, and sleeping medications. In November 2017, the journal PLOS One published research results out of the New Mexico Medical Marijuana Program (“Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study“) that found “a strong correlation between enrollment in an MCP and cessation or reduction of opioid use. From a…
Read more

Cannabis Research, Continuing Education Seminar, Medical Cannabis, National Clinical Conference, Opioids and Other Prescription Drugs, Public Policy, Therapeutic Effects

FDA Sends Warning Letters To CBD Companies About Health Claims

Follow Us!Share This!On October 31, the US Food and Drug Administration sent warning letters to several companies involved in selling products that are reported to contain CBD, over health claims being made by the sellers about their products. According to the FDA: The FDA has grown increasingly concerned at the proliferation of products claiming to treat or cure serious diseases like cancer. In this case, the illegally sold products allegedly contain cannabidiol (CBD), a component of the marijuana plant that…
Read more

Cannabis Industry, News, Public Policy

, ,

Give NFL Players the Option of Medical Cannabis

Follow Us!Share This!Some may claim they just want to get high, yet the players will tell you that cannabis is their medicine; it is the best medicine for their pain and injuries resulting from the numerous hits they take. Frequent hits to the head create cumulative damage that results in serious brain disease called chronic traumatic encephalopathy. Body slams and tackles result in aches and pains throughout the body. These injuries are not limited to football – think of athletes who…
Read more

Medical Cannabis, NFL, Public Policy, State Laws, Therapeutic Effects, Video On Demand

,

Cannabis: Protecting Patients and Reducing Harm

Follow Us!Share This!FOR IMMEDIATE RELEASE Berkeley, CA—May 1, 2017– Physicians, research scientists and faculty from across the U.S. and around the globe will present the latest scientific, medical and clinical research findings May 18 – 20th at Patients Out of Time’s The Eleventh National Clinical Conference on Cannabis Therapeutics: “Cannabis: Protecting Patients and Reducing Harm.” The conference is accredited for CMEs and CEUs and will be held at the Doubletree by Hilton Berkeley Marina in Berkeley, CA. Although the initial…
Read more

California, Cannabis Industry, Cannabis Research, Continuing Education Seminar, Medical Cannabis, National Clinical Conference, Public Policy, State Laws, Therapeutic Effects

, , , , , , , , ,

TSA Does NOT Allow Medical Cannabis Aboard Flights in the US

Follow Us!Share This!The federal Transportation Security Administration does not allow medical cannabis on board any flights in the US. Earlier today a marijuana industry-related blog carried a report that the TSA was officially going to allow patients to bring their medical cannabis with them on board flights. This report was not correct. The story included a purported screenshot of the TSA website. Patients Out of Time checked the TSA site for confirmation, however, and discovered this: Presuming the original story…
Read more

California, Cannabis Industry, Medical Cannabis, Michigan, News, Public Policy, State Laws, Travel, TSA

Faculty Announced For The Eleventh National Clinical Conference On Cannabis Therapeutics

Follow Us!Share This!Faculty members have been announced for The Eleventh National Clinical Conference On Cannabis Therapeutics, which is being held by Patients Out Of Time on May 18-20 2017 in Berkeley, CA. Click here for the full list. Follow Us!Share This!

California, Cannabis Research, Continuing Education Seminar, Federal IND Patients, Medical Cannabis, Public Policy, State Laws, Therapeutic Effects, Veteran Issues

Health Effects of Cannabis and Cannabinoids

Follow Us!Share This!New from the National Academies of Science: Health Effects of Cannabis and Cannabinoids: Current State of Evidence and Recommendations for Research. “Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use…
Read more

Cannabis Research, Medical Cannabis, News, Public Policy, Therapeutic Effects